Semler Scientific sets terms for $15 million IPO

Comment

Shutterstock photo

Semler Scientific, which sells devices that measure arterial blood flow in patients, announced terms for its IPO on Friday. The Portland, OR-based company plans to raise $15 million by offering 1.2 million shares at a price range of $12 to $14. At the midpoint of the proposed range, Semler Scientific would command a fully diluted market value of $62 million. Semler Scientific, which was founded in 2007 and booked $2 million in sales for the 12 months ended 9/30/2013, plans to list on the NASDAQ under the symbol SMLR. Semler Scientific initially filed confidentially on 10/10/2013. Aegis Capital Corp. is the sole bookrunner on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com